Bendamustine,Venetoclax,Rituximab
Roche,Abbvie
['cll']
last presentation by our group at #eha2023, pi arnon kater shares the results of a 7-year follow-up and retreatment study of patients with relapsed/refractory #cll.
it was great congress, see you next year at #eha2024 in madrid! 
News from the Immuno-Hematology group @AmsterdamUMC, researching Chronic Lymphocytic Leukemia. PI's: profs A Kater & E Eldering. Tweets by group members